Our core biotechnology

Enable self-diagnosis

Today's diagnostic tests are too inefficient to deal with endemic infectious disease. The recent pandemic shows that conventional tests have not been able to contain the spread of outbreaks.

At Dianox, we capture insights from breakthrough biotechnologies to develop user friendly diagnostic self-tests. Our platform is based on deep biotechnology and allows us to detect several bacteria and viruses in saliva.

Our biotechnology consists of synthetic molecules in the form of single-stranded DNA folded into complex 3D structures. These artificially engineered molecules can bind with high affinity and specificity to pre-determined targets. A colorimetric reporter is attached to the molecules to provide a distinct visual test result.

Biomarker illustrationSynthetic molecule binding to virus
A diagnostic platform
Employee looking a test sample

Diagnostic testing outside the laboratory

Key advantages of artificially modified antibodies
Synthetic molecules graphic

Synthetic molecules can be designed for any target, including toxic or non-immunogenic ones.

Vector representing accuracy

Made of nucleotides that give increased binding specificity with picomolar affinity to the target.

Hexagon pattern

10x smaller than antibodies, easy to store, can be modified precisely with high batch-to-batch reproducibility.

Dianox Infographics 10 min Fastest diagnostic platform on the market
Fastest diagnostic tool on the market

Opportunity for innovation in diagnostics

Biomarker in test sample

Binding affinity is only part of the equation in the diagnostic process of a commercial test. Other factors such as safety, stability, binding site, shelf life, etc. are often more important. It is critical to utilize biotechnology that accounts for these factors. Synthetic DNA molecules are ideal for developing commercial diagnostic tests.

We perform a biomarker selection using our proprietary process to develop nucleic acids with backbone modifications, which improves target interaction and increases nuclease resistance. Improving conventional diagnostic biotechnologies in terms of cost, development time, and storage conditions. This makes our platform groundbreaking for commercial diagnostic tests.

Button to access the technology page.


Would you like to know more about our technology and its applications?
Button to access the technology page.
Contact us